c-Myc is a transcriptional activator implicated in the control of cell
proliferation, differentiation and transformation, but is also involv
ed in the regulation of programmed cell death, apoptosis. Despite inte
nsive research, the molecular mechanisms by which c-Myc triggers and e
xecutes cell death remain still elusive. Here, we made use of Rat 1A M
ycER cells expressing a conditionally active c-Myc protein and tested
first the hypothesis that ornithine decarboxylase (ODC), which is a tr
anscriptional target of c-Myc, were a mediator of c-Myc-induced apopto
sis. However, our results show that the activity of ODC is not require
d for the c-Myc-mediated apoptosis to occur in these cells. We also fo
und that the expression of p53, p21(waf1/cip1), Bcl-2, Bax, Bcl-x(L),
Bad and cyclins D1, E, A and B did not show any significant changes fo
llowing c-Myc induction. But, our studies revealed that the c-Myc indu
ced apoptosis is associated with a specific cleavage of poly(ADPribose
) polymerase (PARP), suggesting that a cysteine protease of the ICE/CE
D-3 family is involved. Moreover, we found that the cysteine protease
CPP32/Caspase-3, which is known to cleave PARR, is processed from its
inactive form to an active protease composed of 17 and 12 kDa subunits
; whilst Ich-1/Caspase-2 belonging to another subset of this protease
family was not processed/activated following c-Myc activation. The act
ivation of CPP32 and apoptotic cell death were inhibited by addition o
f Z-VAD-fmk, a universal inhibitor of ICE-like proteases. Further, a s
elective inhibitor of CPP32-like proteases (Z-DEVD-fmk) partly inhibit
ed apoptosis. These results provide evidence that the ICE/CED3-family
proteases, CPP32 and likely others, play a critical role in the execut
ion of a nuclear proto-oncogene, c-Myc-induced apoptosis.